Developer docs
API playgroundTry for free, no card

Search company profiles

Enovis Surgical

Full company profile

uuid0021cuo

Namestring
Enovis Surgical
Legal namestring
Enovis Corporation
Websiteurl
djoglobal.com
Company typeenum
Public
Founded yearint
1978
Descriptiontext

Enovis Surgical is the surgical and orthopedic division of Enovis Corporation (NYSE: ENOV), a global medical technology company that designs, manufactures, and distributes devices for musculoskeletal health, surgical reconstruction, recovery, and pain management. The company was founded in 1978 (originally as DJO Global), is headquartered in Wilmington, Delaware with surgical operations based in Vista, California, and employs more than 8,000 people across six continents. Its portfolio spans five primary categories: Bracing and Supports (DonJoy, Aircast, Procare, Exos); Surgical implants (DJO Surgical/Enovis Surgical, Mathys and Lima); Foot and Ankle (Trilliant, MedShape, BetterStep/Novastep); Recovery (Chattanooga, Compex, VitalStim, Manafuse); and Healthcare Solutions (MotionMD, OfficeCare). Notable technology platforms include the ASTRA Arvis surgical navigation and robotics system, the DonJoy Defiance Pro knee brace described as a market leader, and the Manafuse low-intensity pulsed ultrasound bone growth stimulator.

Enovis generates revenue primarily through hardware sales of medical devices via three go-to-market motions: enterprise field sales supported by a Sales Rep Locator tool, channel partnerships through international distributors across Europe, APAC, Africa, and the Americas, and direct-to-consumer e-commerce through branded storefronts (Compex.com, DonJoyStore.com, BetterStep.com). Secondary revenue streams include professional services via medical education programs (CIAO Seminars, US/International Surgical Med Ed) and managed DME services through the MotionMD platform. Pricing is quote-based for B2B healthcare facilities with multi-year contracts; consumer pricing is published on DTC storefronts. Recent acquisitions (Novastep in 2023; Mathys, MedShape, Trilliant Surgical in 2021; LiteCure in 2020) indicate a programmatic M&A strategy to consolidate the orthopedic and foot-and-ankle markets. Q1 2026 revenue of $589 million exceeded analyst consensus of $573.02 million and adjusted EPS of $0.89 beat the $0.81 forecast, though the stock traded at a 52-week low of $20.84 reflecting a 35.12% one-year decline.

Short descriptiontext

Enovis Surgical is a global medical device company (NYSE: ENOV) that manufactures and distributes orthopedic surgical implants, bracing, foot and ankle, and rehabilitation products across six continents, serving surgeons, ambulatory surgery centers, and patients with musculoskeletal conditions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersVista, United States
HQ citystring
Vista
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic medical devices, surgical implants, musculoskeletal health, rehabilitation equipment, orthopedic bracing solutions
Industry4 codes
1Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryYes
2Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
3Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
CodeHLAHAEABPrimaryNo
4Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices)
CodeCRACAQAKPrimaryNo
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Orthopedic Medical Devices
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

Primary revenue from selling orthopaedic medical devices including surgical implants (hip, knee, shoulder, foot/ankle), bracing and support products, rehabilitation equipment, bone growth stimulators, and cold therapy systems. Products sold through direct sales, distributors, and e-commerce channels.

enovis.com
2Professional Services and Medical Education
TypeProfessional Services
Description

Revenue from medical education programs, surgeon training, and professional resources including CIAO Seminars, medical education for US Surgical, International Surgical, and Foot & Ankle specialties.

enovis.com
3Healthcare Solutions (MotionMD/OfficeCare)
TypeManaged Services
Description

Customized DME (Durable Medical Equipment) solutions and consultative healthcare services through MotionMD and OfficeCare platforms.

enovis.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Pricing details1 tier
1B2B Enterprise Pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing for healthcare facilities, surgery centers, and professionals. Contact sales representative for product pricing.

enovis.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1DJO Surgical
Description

High-end surgical products including hip, knee, and upper extremity implants

enovis.com
+9 more records
Core offering1 text field

Enovis Surgical manufactures and distributes medical devices for musculoskeletal health, vascular health, and pain management. The company produces surgical implants (hip, knee, shoulder, upper extremity), orthopedic bracing and supports, foot and ankle implants, bone growth stimulators, and rehabilitation/electrotherapy equipment. It sells these products globally to healthcare professionals, hospitals, ambulatory surgery centers, and directly to patients via branded e-commerce stores.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Q1 2026 revenue of $589 million exceeded analyst forecast of $573.02 million
+2 more records
Product overview1 text field

Enovis Surgical operates as a medical technology company offering a diversified portfolio of clinically differentiated therapeutic solutions. The portfolio includes multiple branded product lines organized across: (1) Bracing & Supports (DonJoy®, Aircast®, Procare®, Exos®) for knee, ankle, shoulder, spine, hand/wrist; (2) Surgical (Enovis Surgical™/DJO Surgical) offering hip, knee, and upper extremity implants plus cement solutions; (3) Foot & Ankle (Trilliant™, MedShape™, BetterStep®/Novastep) covering rearfoot, midfoot, forefoot implants and biologics; (4) Recovery (Chattanooga®, Compex®, VitalStim®, Manafuse®) including therapy systems, muscle stimulators, and bone growth stimulators; and (5) Healthcare Solutions (MotionMD®, OfficeCare) for DME management. The company serves healthcare professionals across six continents with over 8,000 employees, focusing on products that improve patient outcomes and restore movement.

Product and service21 records
1DonJoy®
CategoryOrthopedic Bracing & Supports
Description

Primary orthopedic bracing brand offering knee bracing (including Defiance® Pro ligament bracing and OA bracing), ankle bracing, custom bracing, and cold therapy products for performance, protection, and recovery.

2Aircast®
CategoryOrthopedic Bracing & Supports
Description

Walking braces and ankle bracing products designed for injury protection and rehabilitation.

3Chattanooga®
CategoryRehabilitation & Recovery Equipment
Description

Rehabilitation and recovery brand offering therapy systems, treatment tables, VitalStim electrotherapy and sEMG biofeedback, Manafuse bone growth stimulator, OL1000, and Spinalogic products.

4Compex®
CategoryRehabilitation & Recovery Equipment
Description

Muscle stimulation devices and TENS units for athletes and rehabilitation applications, focused on performance enhancement, recovery, and injury prevention.

5Enovis Surgical™ (DJO Surgical)
CategorySurgical Implants
Description

Surgical implants division offering hip implants, knee implants, upper extremity/shoulder implants, and cement solutions for orthopedic surgery, including ASTRA™ Arvis® surgical navigation and robotics technology.

6Procare®
CategoryOrthopedic Bracing & Supports
Description

Value-oriented orthopedic bracing brand offering wrist braces, knee braces, and ankle braces.

7Trilliant™
CategoryFoot & Ankle Implants
Description

Foot and ankle implant technologies covering rearfoot, midfoot, forefoot, and biologics solutions for foot and ankle conditions.

8MedShape™
CategoryFoot & Ankle Implants
Description

Shape memory alloy and ossimetry products for orthopedic applications, including foot and ankle solutions.

9SpineCare™
CategoryOrthopedic Bracing & Supports
Description

Spinal bracing solutions integrated within the bracing and supports portfolio for spine-related conditions.

10MotionMD®
CategoryHealthcare Solutions / DME Services
Description

Healthcare solutions platform providing a consultative approach to customized durable medical equipment (DME) solutions for healthcare providers and practice management.

11OfficeCare
CategoryHealthcare Solutions / DME Services
Description

Office-based healthcare solutions integrated with MotionMD for practice management and DME workflow.

12BetterStep®
CategoryFoot & Ankle Implants
Description

Minimally invasive bunion correction system developed through the Novastep acquisition, offering the next step in bunion treatment for patients.

13VitalStim®
CategoryRehabilitation & Recovery Equipment
Description

Electrotherapy and sEMG biofeedback system for swallowing therapy (dysphagia) and rehabilitation applications.

14Manafuse®
CategoryBone Growth Stimulation
Description

Low intensity pulsed ultrasound bone growth stimulator for healing non-union fractures.

15Pecaplasty®
CategoryFoot & Ankle Surgical Solutions
Description

Bunion correction system featuring a wires-first approach for surgical simplicity.

16ASTRA™ Arvis®
CategorySurgical Technology
Description

Surgical navigation and robotics technology platform that won the 2026 AWE Auggie Award for Best Healthcare & Wellness Solution, used to support surgical procedures.

17Mathys & Lima Implants
CategorySurgical Implants
Description

Hip and knee implants from partnered manufacturers distributed through the Enovis Surgical division.

18Bone Growth Stimulators
CategoryBone Growth Stimulation
Description

Medical devices including Manafuse and OL1000 for healing non-union fractures and primary lumbar spinal fusion procedures.

19Exos®
CategoryOrthopedic Bracing & Supports
Description

Upper extremity bracing and support products.

20Dr. Comfort®
CategoryTherapeutic Footwear
Description

Therapeutic footwear brand for patients with diabetes and other foot conditions.

21Bell-Horn®
CategoryOrthopedic Bracing & Supports
Description

Orthopedic support brand within the Enovis portfolio.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-06-28
Description

Enovis completed the acquisition of Novastep, a developer of foot and ankle solutions including a minimally invasive bunion system, on June 28, 2023. The acquisition enhances Enovis's position in the bunion market and international segment, strengthening its global position in the foot and ankle market and expanding its innovation portfolio.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest diversified orthopedic and medical device incumbent with overlapping hip/knee implants, surgical navigation (Mako), trauma, and extremities products that compete directly with Enovis Surgical's DJO Surgical franchise.

TypeDirect peer
Description

Direct peer across orthopedic reconstruction, sports medicine, and ENT; competes with Enovis Surgical in hip/knee implants and surgical robotics (CORI).

TypeBroad incumbent
Description

Broad orthopedic incumbent across joint reconstruction, trauma, and spine; competes with Enovis Surgical in hip/knee/shoulder implants and trauma/extremities fixation.

TypeDirect peer
Description

Direct competitor in orthopedic bracing, cold therapy, and DME solutions serving orthopedic practices and ambulatory surgery centers, overlapping with DonJoy, Aircast, and Procare.

TypeDirect peer
Description

Mid-cap peer across orthopedics, extremities, and regenerative technologies; comparable scale and overlapping foot & ankle, trauma, and regenerative product lines.

TypeDirect peer
Description

Private orthopedic sports medicine leader with overlapping foot & ankle and extremities fixation; comparable channel model with strong surgeon education programs.

TypeDirect peer
Description

Orthopedic and surgical peer with comparable mid-cap scale, overlapping sports medicine, foot & ankle, and general surgery device portfolios.

TypeRegional player
Description

Spine-focused peer relevant to Enovis Surgical's SpineCare bracing and bone growth stimulation products; competes for orthopedic surgeon mindshare and hospital budget.

TypeDirect peer
Description

Direct peer in hip and knee reconstruction implants, sports medicine, and surgical robotics; competes head-to-head with Enovis Surgical's Mathys & Lima and DJO Surgical hip and knee portfolios.

TypeDirect peer
Description

Public peer in non-invasive orthopedic devices including bracing and prosthetics; competes with Enovis Surgical's DonJoy, Aircast, and Exos product lines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Enovis Surgical

Orthopedic Medical Devicesdjoglobal.com

Enovis Surgical is a global medical device company (NYSE: ENOV) that manufactures and distributes orthopedic surgical implants, bracing, foot and ankle, and rehabilitation products across six continents, serving surgeons, ambulatory surgery centers, and patients with musculoskeletal conditions.

What Enovis Surgical does

Enovis Surgical is the surgical and orthopedic division of Enovis Corporation (NYSE: ENOV), a global medical technology company that designs, manufactures, and distributes devices for musculoskeletal health, surgical reconstruction, recovery, and pain management. The company was founded in 1978 (originally as DJO Global), is headquartered in Wilmington, Delaware with surgical operations based in Vista, California, and employs more than 8,000 people across six continents. Its portfolio spans five primary categories: Bracing and Supports (DonJoy, Aircast, Procare, Exos); Surgical implants (DJO Surgical/Enovis Surgical, Mathys and Lima); Foot and Ankle (Trilliant, MedShape, BetterStep/Novastep); Recovery (Chattanooga, Compex, VitalStim, Manafuse); and Healthcare Solutions (MotionMD, OfficeCare). Notable technology platforms include the ASTRA Arvis surgical navigation and robotics system, the DonJoy Defiance Pro knee brace described as a market leader, and the Manafuse low-intensity pulsed ultrasound bone growth stimulator.

Enovis generates revenue primarily through hardware sales of medical devices via three go-to-market motions: enterprise field sales supported by a Sales Rep Locator tool, channel partnerships through international distributors across Europe, APAC, Africa, and the Americas, and direct-to-consumer e-commerce through branded storefronts (Compex.com, DonJoyStore.com, BetterStep.com). Secondary revenue streams include professional services via medical education programs (CIAO Seminars, US/International Surgical Med Ed) and managed DME services through the MotionMD platform. Pricing is quote-based for B2B healthcare facilities with multi-year contracts; consumer pricing is published on DTC storefronts. Recent acquisitions (Novastep in 2023; Mathys, MedShape, Trilliant Surgical in 2021; LiteCure in 2020) indicate a programmatic M&A strategy to consolidate the orthopedic and foot-and-ankle markets. Q1 2026 revenue of $589 million exceeded analyst consensus of $573.02 million and adjusted EPS of $0.89 beat the $0.81 forecast, though the stock traded at a 52-week low of $20.84 reflecting a 35.12% one-year decline.

Enovis Surgical firmographics

Firmographics
Name
Enovis Surgical
Legal name
Enovis Corporation
Website
https://djoglobal.com
Company type
Public
Founded year
1978
Operating status
Operating
Headcount range
1–10 employees
Short description
Enovis Surgical is a global medical device company (NYSE: ENOV) that manufactures and distributes orthopedic surgical implants, bracing, foot and ankle, and rehabilitation products across six continents, serving surgeons, ambulatory surgery centers, and patients with musculoskeletal conditions.
Ownership category
akta.pro rank

Enovis Surgical industry classification

Industry
Product category
Orthopedic Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
akta.pro secondary industries
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)

Keywords

  • Orthopedic medical devices
  • Surgical implants
  • Musculoskeletal health
  • Rehabilitation equipment
  • Orthopedic bracing solutions

Where Enovis Surgical is headquartered

Location

Headquarters

HQ city
Vista
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Enovis Surgical business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Medical Device Hardware Sales: Primary revenue from selling orthopaedic medical devices including surgical implants (hip, knee, shoulder, foot/ankle), bracing and support products, rehabilitation equipment, bone growth stimulators, and cold therapy systems. Products sold through direct sales, distributors, and e-commerce channels.
  2. Professional Services and Medical Education: Revenue from medical education programs, surgeon training, and professional resources including CIAO Seminars, medical education for US Surgical, International Surgical, and Foot & Ankle specialties.
  3. Healthcare Solutions (MotionMD/OfficeCare): Customized DME (Durable Medical Equipment) solutions and consultative healthcare services through MotionMD and OfficeCare platforms.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B Enterprise Pricing

Go-to-market motion4 records

Distribution channels5 records

Marketing channels6 records

Enovis Surgical product offering

Product offering

Core offering

Enovis Surgical manufactures and distributes medical devices for musculoskeletal health, vascular health, and pain management. The company produces surgical implants (hip, knee, shoulder, upper extremity), orthopedic bracing and supports, foot and ankle implants, bone growth stimulators, and rehabilitation/electrotherapy equipment. It sells these products globally to healthcare professionals, hospitals, ambulatory surgery centers, and directly to patients via branded e-commerce stores.

Product overview

Enovis Surgical operates as a medical technology company offering a diversified portfolio of clinically differentiated therapeutic solutions. The portfolio includes multiple branded product lines organized across: (1) Bracing & Supports (DonJoy®, Aircast®, Procare®, Exos®) for knee, ankle, shoulder, spine, hand/wrist; (2) Surgical (Enovis Surgical™/DJO Surgical) offering hip, knee, and upper extremity implants plus cement solutions; (3) Foot & Ankle (Trilliant™, MedShape™, BetterStep®/Novastep) covering rearfoot, midfoot, forefoot implants and biologics; (4) Recovery (Chattanooga®, Compex®, VitalStim®, Manafuse®) including therapy systems, muscle stimulators, and bone growth stimulators; and (5) Healthcare Solutions (MotionMD®, OfficeCare) for DME management. The company serves healthcare professionals across six continents with over 8,000 employees, focusing on products that improve patient outcomes and restore movement.

Differentiator

Problem solved

Functional benefit

Brands

  • DJO Surgical: High-end surgical products including hip, knee, and upper extremity implants
  • DonJoy
  • Aircast
  • Chattanooga
  • Compex
  • Procare
  • Trilliant
  • MedShape
  • Exos
  • BetterStep

Products and services

  • DonJoy® Primary orthopedic bracing brand offering knee bracing (including Defiance® Pro ligament bracing and OA bracing), ankle bracing, custom bracing, and cold therapy products for performance, protection, and recovery.
  • Aircast® Walking braces and ankle bracing products designed for injury protection and rehabilitation.
  • Chattanooga® Rehabilitation and recovery brand offering therapy systems, treatment tables, VitalStim electrotherapy and sEMG biofeedback, Manafuse bone growth stimulator, OL1000, and Spinalogic products.
  • Compex® Muscle stimulation devices and TENS units for athletes and rehabilitation applications, focused on performance enhancement, recovery, and injury prevention.
  • Enovis Surgical™ (DJO Surgical) Surgical implants division offering hip implants, knee implants, upper extremity/shoulder implants, and cement solutions for orthopedic surgery, including ASTRA™ Arvis® surgical navigation and robotics technology.
  • Procare® Value-oriented orthopedic bracing brand offering wrist braces, knee braces, and ankle braces.
  • Trilliant™ Foot and ankle implant technologies covering rearfoot, midfoot, forefoot, and biologics solutions for foot and ankle conditions.
  • MedShape™ Shape memory alloy and ossimetry products for orthopedic applications, including foot and ankle solutions.
  • SpineCare™ Spinal bracing solutions integrated within the bracing and supports portfolio for spine-related conditions.
  • MotionMD® Healthcare solutions platform providing a consultative approach to customized durable medical equipment (DME) solutions for healthcare providers and practice management.
  • OfficeCare Office-based healthcare solutions integrated with MotionMD for practice management and DME workflow.
  • BetterStep® Minimally invasive bunion correction system developed through the Novastep acquisition, offering the next step in bunion treatment for patients.
  • VitalStim® Electrotherapy and sEMG biofeedback system for swallowing therapy (dysphagia) and rehabilitation applications.
  • Manafuse® Low intensity pulsed ultrasound bone growth stimulator for healing non-union fractures.
  • Pecaplasty® Bunion correction system featuring a wires-first approach for surgical simplicity.
  • ASTRA™ Arvis® Surgical navigation and robotics technology platform that won the 2026 AWE Auggie Award for Best Healthcare & Wellness Solution, used to support surgical procedures.
  • Mathys & Lima Implants Hip and knee implants from partnered manufacturers distributed through the Enovis Surgical division.
  • Bone Growth Stimulators Medical devices including Manafuse and OL1000 for healing non-union fractures and primary lumbar spinal fusion procedures.
  • Exos® Upper extremity bracing and support products.
  • Dr. Comfort® Therapeutic footwear brand for patients with diabetes and other foot conditions.
  • Bell-Horn® Orthopedic support brand within the Enovis portfolio.

Quantifiable outcome

  • Q1 2026 revenue of $589 million exceeded analyst forecast of $573.02 million
  • +2 more outcomes

Companies that use Enovis Surgical

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Enovis Surgical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Enovis Surgical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • NovastepcoreStrategic or Co-development Partner · 28 June 2023Enovis completed the acquisition of Novastep, a developer of foot and ankle solutions including a minimally invasive bunion system, on June 28, 2023. The acquisition enhances Enovis's position in the bunion market and international segment, strengthening its global position in the foot and ankle market and expanding its innovation portfolio.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Enovis Surgical competitors and assessment

Company assessment

Broad incumbents

  • Stryker: Largest diversified orthopedic and medical device incumbent with overlapping hip/knee implants, surgical navigation (Mako), trauma, and extremities products that compete directly with Enovis Surgical's DJO Surgical franchise.
  • DePuy Synthes (Johnson & Johnson MedTech): Broad orthopedic incumbent across joint reconstruction, trauma, and spine; competes with Enovis Surgical in hip/knee/shoulder implants and trauma/extremities fixation.

Direct peers

  • Smith+Nephew: Direct peer across orthopedic reconstruction, sports medicine, and ENT; competes with Enovis Surgical in hip/knee implants and surgical robotics (CORI).
  • Breg: Direct competitor in orthopedic bracing, cold therapy, and DME solutions serving orthopedic practices and ambulatory surgery centers, overlapping with DonJoy, Aircast, and Procare.
  • Integra LifeSciences: Mid-cap peer across orthopedics, extremities, and regenerative technologies; comparable scale and overlapping foot & ankle, trauma, and regenerative product lines.
  • Arthrex: Private orthopedic sports medicine leader with overlapping foot & ankle and extremities fixation; comparable channel model with strong surgeon education programs.
  • Conmed: Orthopedic and surgical peer with comparable mid-cap scale, overlapping sports medicine, foot & ankle, and general surgery device portfolios.
  • Zimmer Biomet: Direct peer in hip and knee reconstruction implants, sports medicine, and surgical robotics; competes head-to-head with Enovis Surgical's Mathys & Lima and DJO Surgical hip and knee portfolios.
  • Ossur: Public peer in non-invasive orthopedic devices including bracing and prosthetics; competes with Enovis Surgical's DonJoy, Aircast, and Exos product lines.

Regional players

  • NuVasive (now part of Globus Medical): Spine-focused peer relevant to Enovis Surgical's SpineCare bracing and bone growth stimulation products; competes for orthopedic surgeon mindshare and hospital budget.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Enovis Surgical social profiles

Digital presence

Enovis Surgical compliance and trust

Trust signal

Compliance1 record

Enovis Surgical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Enovis Surgical leadership team

Management profile

Number of profiles

Profiles5 records

Enovis Surgical subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Enovis Surgical funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Enovis Surgical M&A and investment

M&A and investment

M&A6 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Enovis Surgical

What does Enovis Surgical do?

Enovis Surgical manufactures and distributes medical devices for musculoskeletal health, vascular health, and pain management. The company produces surgical implants (hip, knee, shoulder, upper extremity), orthopedic bracing and supports, foot and ankle implants, bone growth stimulators, and rehabilitation/electrotherapy equipment. It sells these products globally to healthcare professionals, hospitals, ambulatory surgery centers, and directly to patients via branded e-commerce stores.

Is Enovis Surgical a public or private company?

Enovis Surgical is a public company. It is classified as public and is currently operating.

When was Enovis Surgical founded?

Enovis Surgical was founded in 1978. It employs 1 to 10 people.

Where is Enovis Surgical based?

Enovis Surgical is headquartered in Vista, United States, in the North America region.

How does Enovis Surgical make money?

Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are professional Services and Medical Education and healthcare Solutions (MotionMD/OfficeCare).

Who are Enovis Surgical's main competitors?

Broad incumbents on record are Stryker and DePuy Synthes (Johnson & Johnson MedTech). Direct peers are Smith+Nephew, Breg, Integra LifeSciences, Arthrex, Conmed, Zimmer Biomet and Ossur. NuVasive (now part of Globus Medical) is listed as a regional player.

Does Enovis Surgical have an API?

No public API is recorded for Enovis Surgical.

What industry is Enovis Surgical in?

Enovis Surgical's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comOrthopaedic Implants Market is projected to grow to USD 71.6 billion by 2030 | Zimmer Biomet, Stryker Corporation, Medtronic Plc, Wright Medical Group, CONMED Corporation, Arthrex Inc, DJO GlobalThe orthopedic implants market was valued at USD 44.7 billion in 2022 and is projected to reach USD 71.6 billion by 2030, a CAGR of 6.2% from 2024 to 2031. Growth is driven by aging populations, musculoskeletal disorders, and technological advances like 3D printing and smart coatings.PharmiWeb.comOrthopedic Braces and Support Market to Reach USD 8.8B by 2034The global orthopedic braces and support market is projected to grow from USD 4.6 billion in 2024 to USD 8.8 billion by 2034, driven by rising musculoskeletal disorders, sports injuries, and an aging population. Key growth factors include the adoption of smart technologies, 3D printing for customization, and increased demand for off-the-shelf products via online channels. Major industry players such as DJO Global, Össur, and Bauerfeind are focusing on innovation and strategic partnerships to capture market share amid challenges like reimbursement gaps.Congruence Market InsightsOrthopedic Orthotics Market [2032]A market research report forecasts the global orthopedic orthotics market will grow from USD 3,936.8 million in 2024 to USD 6,866.0 million by 2032, driven by rising musculoskeletal disorders and technological advancements like AI and 3D printing. The United States currently dominates the market due to advanced healthcare infrastructure, while the Asia-Pacific region is projected to register the fastest growth. Key industry players include Össur, DJO Global, and Ottobock, who are investing in R&D to develop customized, smart orthotic solutions.Physio-PediaPartnershipsPhysiopedia collaborates with various global organizations, including the International Committee of the Red Cross and DJO Global, to provide free evidence-based physiotherapy knowledge. These partnerships aim to advance education in under-resourced settings and support professionals through content collaboration and financial contributions.openPR.comPhysiotherapy Equipment Market Strong Industry Growth, Business Strategies, Demand, Emerging Trends, and Forecast 2031 | EMS Physio, BTL Industries, DJO Global Inc., Dynatronics CorporationThe global physiotherapy equipment market reached USD 17.9 billion in 2022 and is projected to grow to USD 29.4 billion by 2031, a CAGR of 6.6%. The market is segmented by product, application, and end user, with major players including EMS Physio, BTL Industries, DJO Global, and Dynatronics.DatainteloIntermittent Pneumatic Compression Devices Market Research Report 2034The global intermittent pneumatic compression devices market was valued at $3.2 billion in 2025 and is projected to reach $5.8 billion by 2034, growing at a compound annual growth rate of 6.8%. Key industry participants driving this expansion include DJO Global, Inc., Tactile Medical, and ArjoHuntleigh through technological innovation and strategic product development. Market growth is primarily fueled by rising incidences of deep vein thrombosis, an aging global population, and expanding reimbursement policies for home-care applications.PR NewswireWorldwide Orthopedic Implants Industry to 2031 - Players Include Medtronic Spinal, DJO Global, Arthrex and NuVasiveResearchAndMarkets.com has added a new market report titled "Orthopedic Implants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031" to its offerings. The report analyzes global market trends, revenue projections from 2017 to 2031, and key industry players including Medtronic Spinal, DJO Global, Arthrex, and NuVasive.PR Newswire3D Printing Revolutionizing the Orthopedic Splints and Casts Market with Tremendous Opportunities, the Market to Mark USD 3.34 Billion by 2027 - AriztonArizton's latest market research report projects the global orthopedic splints and casts market will grow at a CAGR of 6% from 2021-2027, reaching USD 3.34 billion by 2027 from USD 2.34 billion in 2021. The report highlights 3D printing technology as a significant growth opportunity, with emerging companies developing personalized 3D-printed casts and spray-based form splints. APAC is expected to lead regional growth, driven by an aging population and increasing musculoskeletal disorders, while recent market consolidation includes Enovis's USD 3.15 billion acquisition of DJO in 2019 and Breg's partnership expansion in the UK and Australia.BioSpacePhysiotherapy Equipment Market Growth 2022-2028: Rising Number of Cardiovascular And Pulmonary DisordersA market research report by Reports and Data projects the global physiotherapy equipment market to reach USD 24.91 billion by 2028, growing at a CAGR of 5.2%. This growth is driven by rising incidences of cardiovascular, pulmonary, and musculoskeletal disorders, as well an aging population and increased sports injuries. The report identifies major industry players including BTL Industries, DJO Global Inc., and Dynatronics Corporation.PR NewswirePhysiotherapy Equipment Market Size to Grow by USD 7.32 mn | Evolving Opportunities with BTL Group and DJO Global Inc. | TechnavioTechnavio released a 120-page market report projecting the global physiotherapy equipment market will grow by USD 7.32 million between 2021 and 2025, despite a deceleration in growth to a CAGR of 7.40%. North America held approximately 44% of the market share in 2020, driven largely by a rising geriatric population in countries like the US and Canada. The report identifies key industry players including BTL Group, DJO Global Inc., and Dynatronics Corp. as major vendors offering specialized equipment.